Anixa Biosciences's total assets for Q4 2024 were $21.59M, a decrease of -5.75% from the previous quarter. ANIX total liabilities were $2.70M for the fiscal quarter, a 21.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.